ERBB4 and ovarian serous carcinoma: It was found that high-level ERBB4 expression was observed at a significantly higher frequency in ovarian serous carcinoma compared with normal control tissue, indicated that ERBB4 expression may correlate with chemotherapy-resistant ovarian serous carcinoma and shortened OS (26).